Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 2016 Jun 2;94(8):626–630. doi: 10.2471/BLT.15.162461

Point-of-care HIV tests done by peers, Brazil

Tests du VIH effectués par des pairs sur le lieu des soins au Brésil

Pruebas del VIH en el punto de atención realizadas por expertos, Brasil

اختبارات فيروس عوز المناعة البشري في أماكن الرعاية الصحية التي يجريها الأقران في البرازيل

由同伴进行的 HIV 即时检测,巴西

Тестирование на ВИЧ, выполненное по месту оказания медицинской помощи людьми из одной и той же группы населения, Бразилия

Ana Roberta Pati Pascom a,, Clarissa Habckost Dutra de Barros a, Tainah Dourado de Miranda Lobo a, Elisiane Nelcina Pasini a, Regina Aparecida Comparini a, Fábio Caldas de Mesquita a
PMCID: PMC4969986  PMID: 27516641

Abstract

Problem

Early diagnosis of infections with human immunodeficiency virus (HIV) is needed – especially among key populations such as sex workers, transgender people, men who have sex with men and people who use drugs.

Approach

The Brazilian Ministry of Health developed a strategy called Viva Melhor Sabendo (“live better knowing”) to increase HIV testing among key populations. In partnership with nongovernmental organizations (NGOs), a peer point-of-care testing intervention, using an oral fluid rapid test, was introduced at social venues for key populations at different times of the day.

Local setting

Key populations in Brazil can have 40 times higher HIV prevalence than the general population (14.8% versus 0.4%).

Relevant changes

Legislation was reinterpreted, so that oral fluid rapid tests could be administered by any person trained in rapid testing by the health ministry. Between January 2014 and March 2015, 29 723 oral fluid tests were administered; 791 (2.7%) were positive. Among the key populations, transgender people had the greatest proportion of positive results (10.7%; 172/1612), followed by men who declared themselves as commercial sex workers (8.7%; 165/1889) and men who have sex with men (4.8%; 292/6055).

Lessons learnt

The strategy improved access to HIV testing. Testing done by peers at times and locations suitable for key populations increased acceptance of testing. Working with relevant NGOs is a useful approach when reaching out to these key populations.

Introduction

To respond to the human immunodeficiency virus (HIV) epidemic it is important to diagnose HIV-infected people early, because diagnosis allows infected people to start antiretroviral therapy (ART) and – by reducing their viral load – reduces HIV transmission.1 However, fear of the disease and the consequences of being infected make people hesitant to test themselves for HIV.24

Key populations –men who have sex with men, transgender people, sex workers and people who use drugs – are disproportionally affected by the HIV epidemic.5 Their risk of infection is higher than the general population and they face legal and social barriers in accessing health services. To improve access to HIV care and diagnosis, community-based interventions are essential.6,7

To expand HIV testing for key populations in Brazil, the health ministry developed a community-based testing strategy, called Viva Melhor Sabendo (“live better knowing”). We present lessons learnt during the first 15 months of its implementation.

Local context

In Brazil, the HIV epidemic is largely concentrated in key populations. For men who have sex with men, prevalence was 14.8% in 2015, 40 times higher than in the general population (0.4% in 2012). In other key populations the prevalence is about 5% (female commercial sex workers 4.9% in 2009; drug users 5.0% in 2013).812

The Brazilian acquired immunodeficiency syndrome (AIDS) programme has a set of preventive actions for key populations such as financial support for specific activities, distribution of educational and prevention materials – such as male and female condoms – and workshops on HIV prevention. These actions are done in partnership with nongovernmental organizations (NGOs). Since 2013, the health ministry aims to provide ART to every person living with HIV, irrespective of their CD4+ T-lymphocyte count.13

Approach

Once the programme implemented treatment as prevention, early diagnosis emerged as the next requirement, especially for key populations. To meet this need, the Department of Sexually Transmitted Infections (STIs), AIDS and Viral Hepatitis developed a key populations-focused strategy, which combined prevention, testing and counselling initiatives. The strategy included a peer point-of-care testing intervention with an oral fluid HIV rapid test. The test, DPP® HIV-1/2 (Biomanguinhos/Fiocruz, Rio de Janeiro, Brazil), is only for screening when administered alone, despite its high sensitivity (99.5%) and specificity (99.0%).14 Therefore, any positive result from an oral fluid rapid test needs diagnostic confirmation through a finger puncture rapid test or another conventional test. To include the combination of two rapid tests – either two finger puncture rapid tests or one oral fluid test and one finger puncture test – in HIV diagnosis, national algorithms for HIV testing had to be updated.15 Moreover, legislation had to be reinterpreted through a ministerial decree so that the administration of oral fluid HIV rapid tests would no longer be restricted to health professionals, but open to any person trained in rapid testing by the health ministry.16

In partnerships with selected NGOs, the department ran a pilot project for the strategy between January 2014 and March 2015. The department selected 53 NGOs from all five geographical regions of Brazil through a bidding process that considered the NGOs’ experience in community work with key populations.

To support the implementation of the project, people from the health ministry held a two-day training session for NGO staff involved, either at the NGO’s office or at the local STI/AIDS and viral hepatitis coordination office. Staff were trained to implement the project by learning to develop an action plan; carry out the oral fluid test; counsel the person tested; inform only the patient of the results; make a referral to health services; and monitor the project.

The ministry provided NGOs with a booklet detailing the methods of the strategy and a training video showing how to do the tests.

When planning the interventions, NGOs and the local STI, AIDS and viral hepatitis coordinator mapped testing sites and coordinated referral services with local health management and municipal health facilities.

The NGO teams did all the work, from offering the test to referring those who tested positive to HIV services. The teams were free to develop their own ways of approaching people for testing. To improve uptake, the teams used their knowledge of each key population and their previous experience with community work. When possible, team members chose to approach people of the same population; for example, a transgender team member approached another transgender person. The teams carried out oral fluid testing at different times of the day in social venues they had mapped. The testing was free of charge and voluntary and the results were only revealed to the tested person. Although anyone could be tested at the venues, peers only offered tests to people they thought were part of the key populations. To be tested, the person had to fill out a consent form for taking the test and a registration form, which contained demographic information and information about the possible route of HIV transmission. Individual identification was not compulsory. Team members gave people with positive test results the address of a health facility where diagnosis could be confirmed and treatment and care provided. For those who chose not to provide personal identifiers on the registration form, the teams were unable to confirm enrolment in care.

The department developed a special monitoring and evaluation plan, a field log, monthly activity worksheets and technical reports with data collected during testing. Information from the registration form was inserted in SIMAV-pro, an online monitoring system that was developed specially for this strategy.

To ensure that those who tested positive got a confirmation and were referred to the local health services, a team from the department mediated NGOs’ contacts with local management and health services. The team also made frequent visits to the NGOs to ensure high-quality testing.

The results presented here are from a secondary analysis of data obtained anonymously during the implementation of the strategy, hence ethical approval of the study was not required.

Relevant changes

During the pilot project, 29 723 oral fluid tests were administered; 791 (2.7%) were positive (Table 1). Transgender people had the highest proportion of positive results (10.7%; 172/1612), followed by men who declared themselves as commercial sex workers (8.7%; 165/1889) and men who have sex with men (4.8%; 292/6055). Of the 224 people who reported to have had at least one STI in the last 12 months before the test, 162 (7.2%) had a positive result.

Table 1. Characteristics of people tested for HIV with oral fluid rapid test, Brazil, January 2014 to March 2015.

Characteristics No. tested No. with a positive result (%) Pa
All 29 723 791 (2.7)
Age, years 0.002
≤ 24 9 320 209 (2.2)
25–34 9 776 259 (2.6)
35–49 7 058 227 (3.2)
≥ 50 3 190 82 (2.6)
Sex 0.001
Female 13 085 205 (1.6)
Male 16 546 583 (3.5)
Education 0.021
Incomplete primary 4 856 156 (3.2)
Complete primary 11 236 295 (2.6)
High school or more 13 382 330 (2.5)
Population subgroup < 0.001
Transgender 1 612 172 (10.7)
Men who have sex with men 6 055 292 (4.8)
Heterosexual man 9 253 153 (1.7)
Heterosexual woman 1 122 6 (0.5)
Bisexual man 1 852 26 (1.4)
Homosexual woman 9 618 140 (1.5)
Sex work < 0.001
No sex work 21 986 513 (2.3)
Male sex worker 1 889 165 (8.7)
Female sex worker 5 848 113 (1.9)
Use of psychoactive substances < 0.001
None 9 918 225 (2.3)
One 13 554 354 (2.6)
Two 3 661 123 (3.4)
Three 1 757 50 (2.8)
Four or more 833 39 (4.7)
Had at least one HIV test in lifetime < 0.001
Yes 13 760 240 (1.7)
No 15 646 532 (3.4)
Had any STI during the last 12 months < 0.001
No 27 118 614 (2.3)
Yes 2 244 162 (7.2)

HIV: human immunodeficiency virus; STI: sexually transmitted infection.

a To assess the differences in the proportions in each group, we conducted χ2 tests.

Note: Due to missing information, the sum of people in each sub-category does not add up to the total number of people tested.

Thirty-nine (4.7%) individuals of the 833 who reported use of at least four psychoactive substances (regardless of whether the substances were injectable or not) had positive results – twice as much as for those who did not report any use of psychoactive substances (2.3%; 225/9918; Table 1).

The proportion of positive results among people who were receiving their first HIV test (3.4%; 532/15 646) was twice the proportion observed among those who had already been tested at least once (1.7%; 240/13 760; Table 1).

The total cost of the pilot project was 643 882 United States dollars.

Lessons learnt

A specific focus on increasing testing among key populations with the highest HIV burden9,10,12 resulted in an increase of early diagnoses. Two factors played a role in the increase. First, changes in the testing algorithm made it possible for trained peers to do the testing instead of health professionals. Second, the use of a non-invasive test for screening facilitated testing outside health-care centres.

The main lessons learnt are summarized in Box 1. Peer point-of-care using an oral fluid HIV test facilitated access for key populations to HIV testing and counselling. Furthermore, the people involved showed an increased acceptance of HIV testing, because the test was done by peers in convenient places and times of the day. The strategy also empowered the people working for participating NGOs by improving their ways of addressing key populations, increasing their knowledge about venues of social interest and tightening their relationship with the local health services. NGO team members developed skills and solved problems that moved the strategy forward.

Box 1. Summary of main lessons learnt.

The strategy was designed to provide testing and prevention initiatives for populations with the highest human immunodeficiency virus (HIV) prevalence.

By reaching the key populations in their own environment, the peer-testing strategy increased HIV testing among people with higher HIV burden.

People accepted this testing strategy, in part because they were not exposed to possible discrimination experienced when visiting traditional health services.

The strategy promoted contacts between the Brazilian Federal Government and state and municipal STI and HIV/AIDS management. This kind of connection plays an important role within the operation of the Brazilian Unified Health System, since Brazil’s three government spheres – the union, states and municipalities – are mutually independent and their autonomy is ensured by the Brazilian Federal Constitution.

The proportion of positive tests identified during the project was almost seven times higher than in the general population – 2.7% versus 0.4%,9 respectively. This difference reinforces the need to expand initiatives focusing on the key populations to respond to the HIV epidemic in Brazil.

Acknowledgements

The authors thank the participating NGOs and the team from the Brazilian Ministry of Health’s Department of STIs, AIDS and Viral Hepatitis.

Competing interests:

None declared.

References

  • 1.Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. ; HPTN 052-ACTG Study Team. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014. April;14(4):281–90. 10.1016/S1473-3099(13)70692-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, et al. ANRS-COM’TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open. 2012;2(2):e000693. 10.1136/bmjopen-2011-000693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ntsepe Y, Simbayi LC, Shisana O, Rehle T, Mabaso M, Ncitakalo N, et al. Perceptions about the acceptability and prevalence of HIV testing and factors influencing them in different communities in South Africa. SAHARA J. 2014;11(1):138–47. 10.1080/17290376.2014.937355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3) Suppl 2:18734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.HIV prevention, diagnosis, treatment and care for key populations [Policy brief]. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/10665/128049/1/WHO_HIV_2014.8_eng.pdf?ua=1&ua=1 [cited 2016 May 10].
  • 6.Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. ; Investment Framework Study Group. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011. June 11;377(9782):2031–41. 10.1016/S0140-6736(11)60702-2 [DOI] [PubMed] [Google Scholar]
  • 7.Service delivery approaches to HIV testing and counselling (HTC): a strategic HTC programme framework. Geneva: World Health Organization; 2012. Available from: http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877_eng.pdfhttp://[cited 2015 Aug 7].
  • 8.Szwarcwald CL, Pascom ARP, Souza-Jr PRB. Estimation of the HIV incidence and of the number of people living with HIV/AIDS in Brazil, 2012. J AIDS Clin Res. 2015;6(03):3 10.4172/2155-6113.1000430 [DOI] [Google Scholar]
  • 9.Bertoni N, Burnett C, Cruz MS, Andrade T, Bastos FI, Leal E, et al. Exploring sex differences in drug use, health and service use characteristics among young urban crack users in Brazil. Int J Equity Health. 2014;13(1):70. 10.1186/s12939-014-0070-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Damacena GN, Szwarcwald CL, de Souza Júnior PR, Dourado I. Risk factors associated with HIV prevalence among female sex workers in 10 Brazilian cities. J Acquir Immune Defic Syndr. 2011. August;57 Suppl 3:S144–52. 10.1097/QAI.0b013e31821e9bf6 [DOI] [PubMed] [Google Scholar]
  • 11.de Sousa Mascena Veras MA, Calazans GJ, de Almeida Ribeiro MC, de Freitas Oliveira CA, Giovanetti MR, Facchini R, et al. ; SampaCentro Study Group. High HIV prevalence among men who have sex with men in a time-location sampling survey, São Paulo, Brazil. AIDS Behav. 2015. September;19(9):1589–98. 10.1007/s10461-014-0944-3 [DOI] [PubMed] [Google Scholar]
  • 12.Kerr LR, Mota RS, Kendall C, Pinho AA, Mello MB, Guimarães MD, et al. ; HIVMSM Surveillance Group. HIV among MSM in a large middle-income country. AIDS. 2013. January 28;27(3):427–35. 10.1097/QAD.0b013e32835ad504 [DOI] [PubMed] [Google Scholar]
  • 13.[Clinical protocol and guidelines of treatment for the management of the HIV infection in adults.] Brasília: Brazilian Ministry of Health; 2013. Available from: http://www.aids.gov.br/sites/default/files/anexos/publicacao/2013/55308/protocolofinal_31_7_2015_pdf_31327.pdf [cited 2015 Aug 7]. Portuguese.
  • 14.Cappello JM, Gunasekera A, Gunasekera D, Esfandiari J, Ippolito T. A multicenter performance evaluation of the DPP(®) HIV-1/2 assay for the detection of HIV antibodies in various HIV testing algorithms. J Clin Virol. 2013. December;58 Suppl 1:e59–64. 10.1016/j.jcv.2013.08.032 [DOI] [PubMed] [Google Scholar]
  • 15.Secretaria De Vigilância Em Saúde. Portaria nº 29, de 17 de dezembro de 2013. Aprova o manual técnico para o diagnóstico da infecção pelo hiv em adultos e crianças e dá outras providências [Dario Oficial da Uniao]. Brasília: Brazilian Ministry of Health; 2013. Available from: http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina=59&data=18/12/2013 [cited 2016 May 18]. Portuguese.
  • 16.[Technical manual for diagnosis of infection by HIV.] Brasília: Brazilian Ministry of Health; 2014. Available from: http://www.aids.gov.br/sites/default/files/anexos/publicacao/2013/55594/manual_tecnico_para_o_diagnostico_da_infeccao_pelo_17627.pdf [cited 2015 Aug 7]. Portuguese.

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES